83 related articles for article (PubMed ID: 10209841)
1. [Quality of life following transplantation. The impact ofa new immunosuppressive substance].
Lütkes P; Franke G; Witzke O; Zimmermann U; Kohnle M; Philipp T; Heemann U
Zentralbl Chir; 1999; 124(2):90-4. PubMed ID: 10209841
[TBL] [Abstract][Full Text] [Related]
2. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
3. A quality of life comparison in cyclosporine- and tacrolimus-treated renal transplant recipients across Canada.
Prasad GV; Nash MM; Keough-Ryan T; Shapiro RJ
J Nephrol; 2010; 23(3):274-81. PubMed ID: 20383867
[TBL] [Abstract][Full Text] [Related]
4. Steroid-free immunosuppression in kidney transplant recipients and prograf monotherapy: an interim analysis of a prospective multicenter trial.
Bäckman L; Aselius H; Lindberger K; Svensson L; Strömbom U; Olausson E; Hadimeri H; Deurell SI; Norrby J; Gäbel M; Ebermark A; Olausson M
Transplant Proc; 2006 Oct; 38(8):2654-6. PubMed ID: 17098029
[TBL] [Abstract][Full Text] [Related]
5. A numerical scale comparison of renal transplant recipient experience with and opinions about calcineurin inhibitors.
Prasad GV; Nash MM; McFarlane PA; Zaltzman JS
Nephron Clin Pract; 2004; 97(2):c35-40. PubMed ID: 15218328
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
7. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
[TBL] [Abstract][Full Text] [Related]
8. [Quality of life after kidney transplantation].
Milutinović D; Hadzi-Djokić J; Blagojević-Lazić R; Borić Z
Acta Chir Iugosl; 1999; 46(1 Suppl):35-7. PubMed ID: 10951776
[TBL] [Abstract][Full Text] [Related]
9. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation.
Barone GW; Ketel BL; Abul-Ezz SR; Lightfoot ML
JOP; 2002 Mar; 3(2):49-53. PubMed ID: 11884766
[TBL] [Abstract][Full Text] [Related]
10. Improvement of quality of life in tacrolimus-based pediatric renal transplant recipients and their caregivers, including donors.
Hasegawa A; Oshima S; Takahashi K; Uchida K; Ito K; Sonoda T
Transplant Proc; 2005 May; 37(4):1771-3. PubMed ID: 15919461
[TBL] [Abstract][Full Text] [Related]
11. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus.
Chamienia A; Biedunkiewicz B; Król E; Debska-Slizień A; Rutkowski B
Transplant Proc; 2006; 38(1):81-5. PubMed ID: 16504670
[TBL] [Abstract][Full Text] [Related]
12. Switching from cyclosporine to tacrolimus leads to improved disease-specific quality of life in patients after kidney transplantation.
Franke GH; Trampenau C; Reimer J;
Transplant Proc; 2006 Jun; 38(5):1293-4. PubMed ID: 16797285
[TBL] [Abstract][Full Text] [Related]
13. Effects of and predictors for tacrolimus rescue therapy among renal transplant patients under cyclosporine-based immunosuppression.
Hu RH; Lee CY; Tsai MK; Lee PH
Transplant Proc; 2004 Sep; 36(7):2092-5. PubMed ID: 15518757
[TBL] [Abstract][Full Text] [Related]
14. Renal function in patients with cadaveric kidney transplants treated with tacrolimus or cyclosporine.
Gonzalez Molina M; Morales JM; Marcen R; Campistol JM; Oppenheimer F; Serón D; Gil-Vernet S; Capdevila L; Andrés A; Lampreave I; Del Castillo D; Cabello M; Burgos D; Valdés F; Anaya F; Escuín F; Arias M; Pallardó L; Bustamante J
Transplant Proc; 2007 Sep; 39(7):2167-9. PubMed ID: 17889126
[TBL] [Abstract][Full Text] [Related]
15. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.
Jain AK; Venkataramanan R; Shapiro R; Scantlebury VP; Potdar S; Bonham CA; Ragni M; Fung JJ
Liver Transpl; 2002 Sep; 8(9):841-5. PubMed ID: 12200788
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
Waid T;
Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus based immunosuppression.
First MR
J Nephrol; 2004; 17 Suppl 8():S25-31. PubMed ID: 15599882
[TBL] [Abstract][Full Text] [Related]
18. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
Kim HC; Hwang EA; Han SY; Park SB; Kim HT; Cho WH
Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine.
Horowitz MM; Przepiorka D; Bartels P; Buell DN; Zhang MJ; Fitzsimmons WE; Erdman J; Huang C; Hodosh E; Maher R; Wingard JR
Biol Blood Marrow Transplant; 1999; 5(3):180-6. PubMed ID: 10392964
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus and quality of life after kidney transplantation--a multicenter study.
Bohlke M; Rocha M; Gomes RH; Marini SS; Terhorst L; Barcellos FC; Hallal PC; Casarini D; Irigoyen MC
Clin Transplant; 2006; 20(4):504-8. PubMed ID: 16842529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
